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Background: Alzheimer’s disease (AD) and dementia are chronic diseases with
progressive deterioration of cognition, function, and behavior leading to severe disability
and death. The prevalence of AD and dementia is constantly increasing because of
the progressive aging of the population. These conditions represent a considerable
challenge to patients, their family and caregivers, and the health system, because of the
considerable need for resources allocation. There is no disease modifying intervention for
AD and dementia, and the symptomatic pharmacological treatments has limited efficacy
and considerable side effects. Non-pharmacological treatment (NPT), which includes a
wide range of approaches and techniques, may play a role in the treatment of AD and
dementia.
Aim: To review, with a narrative approach, current evidence on main NPTs for AD and
dementia.
Methods: PubMed and the Cochrane database of systematic reviews were searched
for studies written in English and published from 2000 to 2018. The bibliography of the
main articles was checked to detect other relevant papers.
Results: The role of NPT has been largely explored in AD and dementia. The
main NPT types, which were reviewed here, include exercise and motor rehabilitation,
cognitive rehabilitation, NPT for behavioral and psychological symptoms of dementia,
occupational therapy, psychological therapy, complementary and alternative medicine,
and new technologies, including information and communication technologies, assistive
technology and domotics, virtual reality, gaming, and telemedicine. We also summarized
the role of NPT to address caregivers’ burden.
Conclusions: Although NPT is often applied in the multidisciplinary approach to AD
and dementia, supporting evidence for their use is still preliminary. Some studies showed
statistically significant effect of NPT on some outcomes, but their clinical significance is
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uncertain. Well-designed randomized controlled trials with innovative designs are needed
to explore the efficacy of NPT in AD and dementia. Further studies are required to offer
robust neurobiological grounds for the effect of NPT, and to examine its cost-efficacy
profile in patients with dementia.
Keywords: Alzheimer’s disease, dementia, non-pharmacological intervention, rehabilitation, caregiver,
interprofessional team
INTRODUCTION
Dementia represents one of the major health problems in
elderly individuals, with progressive deterioration of cognition,
daily activity functioning and behavior that together lead to
disability. Worldwide, approximately 40 million people over
65 years suffer from dementia, and 70% of them are affected
by Alzheimer’s disease (AD) that represents the most diffuse
type of dementia. The incidence of dementia increases with
age, which is the most important risk factor. Therefore, the
prevalence of AD is expected to increase in the future, in
parallel with the progressive aging of the population. In the
European Union, the most reliable estimates forecast dementia
cases to overcome 15 million in 2020 (1–3). Moreover, the
improved life conditions in developing countries will lead to
increased life expectancy, and therefore to higher incidence of
dementia (4).
No disease-modifying treatment has been demonstrated to be
effective in AD. Cholinesterase inhibitors and memantine, which
are the only commercially available symptomatic drugs, may
improve cognitive and behavioral outcomes, but their clinical
impact remains modest and controversial (5–7). Despite research
has been focused on the early [i.e., mild cognitive impairment
(MCI) with biological evidence of AD] or preclinical stages of
the disease, and new disease-modifying treatments have been
tested to reduce the supposed pathophysiological changes of AD
(i.e., amyloid deposition), no significant clinical effect has been
achieved, to date (8).
Because of the limited efficacy of current pharmacological
therapy and with the knowledge that caring for people
with AD and dementia requires the involvement of a large
number of professionals (e.g., psychologists, occupational
therapists, etc.) and caregivers to offer a comprehensive
and individualized management, research focused on non-
pharmacological treatment (NPT). NPT may improve function,
independence, and quality of life (QoL) in agreement with the
International Classification of Functioning, Disability and Health
(ICF) (9), is non-invasive, safe and has few side effects (10). NPT
encompasses a wide range of interventions to improve patients’
symptoms, reduce the stress of caregivers, and ameliorate
the environment. NPT is based on different methodologies,
ranging from simpler (e.g., environmental interventions) to
complex approaches (e.g., virtual reality, home automation) (11).
These interventions are not aimed to influence the underlying
pathophysiological mechanisms but to maintain function and
participation as long as possible, as the disease progresses,
thus reducing disability and improving patient’s and caregiver’s
QoL. However, a direct effect of NPT on cognition through
neural plasticity/adaptation cannot be excluded in early disease
stages.
The present narrative review summarized evidence on NPTs
for AD and dementia. Because of the large bulk of data on this
topic, we focused on the main NPT strategies. We did not report
and discuss data on NPT in MCI, an intermediate state between
intact cognition and dementia (12), because of the large number
of studies that would have required a paper apart.
SEARCH STRATEGY
PubMed and the Cochrane database of systematic reviews
were searched for studies published from 2000 to 2018 with
a search string including the following terms: Alzheimer’s
disease, dementia, behavioral and psychological symptoms,
non-pharmacological, intervention, therapy, exercise, motor,
rehabilitation, neurorehabilitation, cognitive, training,
stimulation, occupational, psychological, psychotherapy,
multicomponent, multidimensional, complementary and
alternative medicine, aromatherapy, music therapy, art
therapy, massage and touch, technology, information and
communication, assistive device, domotics, virtual reality,
gaming, serious games, telemedicine, related terms, and
MeSH. Only papers written in English were considered. The
bibliography of the main articles (reviews, systematic reviews,
meta-analyses) was also checked to detect other relevant
papers.
In consideration of the great heterogeneity of interventions
that are classified as NPT and of the variety of outcome measures
reported in the different studies, this work was not conceived as
a systematic review of the literature, but as a narrative one to
provide a useful tool for clinicians on the state of the art of NPT
in dementia.
EXERCISE AND MOTOR REHABILITATION
A growing amount of evidence suggests that a healthy
lifestyle can reduce the risk of cardiovascular diseases (13,
14), osteoporosis, diabetes, and depression (15). A number of
prospective cohort studies suggested that a regular physical
activity may enhance cognitive function and reduce the risk of
AD and other dementias and delay their onset or progression
(16–24). A recent paper derived from the population-basedMayo
Clinic study of aging on 280 MCI patients showed that moderate
intensity midlife physical activity was significantly associated
with a decreased risk of incident dementia (25). Regular physical
exercise is recommended to all older adults, and indeed to those
Frontiers in Neurology | www.frontiersin.org 2 December 2018 | Volume 9 | Article 1058
Zucchella et al. Non-Pharmacological Treatment of Dementia
at increased risk of AD, as it may improve physical health, reduce
frailty, lower the risk of depression, improve cognitive function
in the short and long term (26–31).
Conversely, the evidence on the protecting role of short-term,
single-component physical activity interventions seems to be
largely insufficient (32).
Exercise has been documented to improve physical health
and well-being (33), to reduce behavioral and psychological
symptoms of dementia (BPSD) (34–36), and to enhance
performance in the activities of daily living (ADL) (37, 38) in
patients with AD or dementia.
A Cochrane review including 17 randomized controlled trials
(RCTs) confirmed the positive effect of exercise programs in
reducing the progression of dependence in ADL in people
with dementia but showed limited evidence of benefit for the
remaining outcomes (i.e., cognition, BPSD, QoL, depression,
mortality, caregiver burden, and use of healthcare services)
(39). This finding is of some relevance because preserving
functional independence in ADL is critical for improving the
QoL of people with dementia and their caregivers and delaying
institutionalization.
The exercise interventions explored in dementia include a
variety of training methods (e.g., aerobic exercise, resistance
training or weightlifting, balance, and flexibility training), and
the physical/motor outcome measures were quite different across
studies (e.g., chair stand tests, timed up and go, timed walking
tests). Comparative studies to explore the most effective exercise
intervention, the amount of exercise, the most sensitive and
significant outcome, and the role of physical activity in different
patients’ groups are needed.
According to animal models, a number of mechanisms may
mediate the effects of exercise on brain and cognition (40). It
has been suggested that exercise may improve vascular health by
reducing blood pressure (41, 42), arterial stiffness (42), oxidative
stress (43), systemic inflammation (44), and enhance endothelial
dysfunction (45), all of which are associated with better cerebral
perfusion (46, 47). Exercise may also preserve neurons and
promote neurogenesis, synaptogenesis, (48–50), and neuronal
plasticity (51–55).
Imaging studies in aging people confirmed the positive
association between physical activity and gray matter volume.
Both aerobic fitness and coordinative exercises was associated
with reduced brain atrophy in the frontal and temporal regions
and the hippocampus, all areas that are critical for higher
cognitive function (56–58). A recent review on the association
between fitness, physical activity and gray matter volume showed
that both cross-sectional studies and randomized interventions
consistently suggested a change in the size of prefrontal cortex
and hippocampus after moderate intensity exercise in elderly
people (59).
Neurotrophins, in particular the brain-derived neurotrophic
factor, may be the common pathway of these mechanisms,
may mediate the exercise-driven brain responses and can drive
neuronal plasticity, improve cognition, and protect neurons
against insult (60–63).
Future studies aimed to identify lifestyle, behavioral and/or
biologic factors that may increase the likelihood of successful
brain aging would help implementing preventive intervention to
reduce age-related brain atrophy and consequently the risk for
cognitive decline.
Conversely, the effect of physical exercise on other biological
measures of AD pathology, such as cerebrospinal fluid
biomarkers is still unclear (64, 65), and further studies are
needed on this topic.
COGNITIVE INTERVENTION
Cognitive intervention is currently the NPT that has been better
explored in dementia and represents the most robust alternative
and/or complement to pharmacological treatment. Cognitive
intervention is typically classified as cognitive stimulation (CS),
cognitive training (CT), and cognitive rehabilitation (CR) (66).
CS refers to a broad range of activities (i.e., reality orientation
therapy, reminiscence therapy) aimed to enhance the general
cognitive and social functioning of the individual (67). While
CS consists in a global approach to arouse all cognitive
domains, CT focuses on a particular cognitive function (e.g.,
attention, memory, executive functions, language) through a set
of standard tasks to improve or maintain—as is the case for
neurodegenerative diseases—its normal functioning as long as
possible. CR refers to a tailor-made approach which sets realistic
goals to help patients and their families in everyday life. To
achieve these aims, the CR therapist may choose a restorative or
a compensative approach (68).
Even though the distinction between CS, CT, and CR is
clear, the literature on cognitive interventions is, to some extent,
confused. These terms are often used interchangeably, even
if they refer to distinct approaches with a different rationale.
Moreover, CR has been rarely used in dementia, because it may
be difficult to apply in this condition. For these reasons, our
review will focus on studies exploring CS or CT for people with
dementia.
CS is currently the intervention with themost robust evidence.
Several studies reported an improvement of general cognitive
functioning in patients with mild-to-moderate dementia after
CS sessions of variable length (69–74). A recent meta-analysis
showed that CS has a moderate effect size on the Mini
Mental State Examination (75) and a small effect size on
the Alzheimer’s Disease Assessment Scale-cognitive subscale
(76), which represent two commonly-used general cognitive
functioning outcomes, in patients with dementia (73). There are
still few data on the efficacy of CS on other outcomes, such
as mood, behavioral symptoms, QoL, and well-being. However,
preliminary results indicate that CS may improve QoL and well-
being of caregivers of people with AD and dementia (69, 70, 74).
The evidence on CT for people with dementia is less robust.
A recent systematic review indicated that CT may improve
patient’s performance in trained tasks and similar exercises but
has no consistent effect on everyday functioning (77). Most RCTs
showed no effect of CT on other outcomes, but their low quality
impede any solid conclusion (70–72, 74, 77).
Some studies documented the association of CS and CT did
not result in better outcomes than single interventions (73, 74).
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The Cognitive Stimulation Therapy (CST) was proposed
as a structured and methodologically sound CS protocol (78,
79). CST is currently considered the evidence-based NPT of
choice for the cognitive symptoms ofmild-to-moderate dementia
of any etiology, including vascular one (80–83). Moreover,
CST is at present, the only one for which international RCTs
consistently demonstrated significant improvements to cognition
and QoL, using the same CST program which has been culturally
adapted using standardized guidelines. CST involves 14 or
more sessions of themed activities, usually related to tasks
including money use, word games, word association, object
categorization, current affairs and famous faces, and is typically
run twice weekly (78). Each CST session is aimed to stimulate
cognitive abilities and social relationships with other members
and operators (78, 79). Several studies suggested the area of
major CST efficacy in people with mild-to-moderate dementia is
general cognitive functioning, but some cognitive areas, namely
memory, orientation and language comprehension seems to
be those with larger improvement following CST in an open
study (84).
Several issues (e.g., health or mobility problems, services not
offering this treatment) could undermine the participation of
patients with dementia to CST groups (85) and the interest
for individualized CST (iCST) is increasingly growing (85, 86).
However, a recent RCT showed that a home-based iCST program
had neither effect on cognition and QoL of patients with mild-
to-moderate dementia, nor on QoL of their caregivers (87).
The reasons for this negative finding might include the lack
of additional stimulation from participation in a group social
context and the difficulty for the caregiver to administer the iCST
program in the proper way, being not professional, and because
of the difficult relationship with the person with dementia.
In conclusion, while the CST program—a precise technique
with a specific manual and training—has a robust evidence-based
body of data, the high heterogeneity in terms of duration of
treatment, length, and number of single sessions and severity of
dementia impede any definite conclusion on the efficacy of other
CS and CT interventions (73).
NON-PHARMACOLOGICAL
MANAGEMENT OF BEHAVIORAL AND
PSYCHOLOGICAL SYMPTOMS OF
DEMENTIA
Behavioral and psychological symptoms of dementia, i.e., the
so-called BPSD, are characterized by alterations of perception
(hallucinations, misidentification), thinking (delusions), mood
(depression, anxiety, apathy), and behavior (aggression,
agitation, disinhibition, wandering, socially or sexually
inappropriate behavior) (88), being highly prevalent in all
types of dementia, i.e., 50–80% in AD, >80% in fronto-temporal
dementia, 50–70% in Lewy body dementia and vascular
dementia (89, 90). BPSD may occur in all stages of AD, and
even in people with MCI, but there is no agreement on the
possible relationship with disease evolution. Indeed, although
some studies showed that the prevalence and severity of BPSD
increase with dementia severity, other reports suggest they
are more frequent in the moderate AD stages, and diminish
with disease progression (89, 90). Factors that may influence
BPSD occurrence include premorbid personality, younger age,
poor education, depression, high burden, concurrent medical
conditions, and drugs. Environmental factors such as noise,
overstimulation, isolation, inadequate temperature, change of
routine, as well as inappropriate relationship between patient
and caregiver (e.g., communication style, body language) or
the inability of the patient to express his needs, may all trigger
BPSD (91).
BPSD represent themost frequent cause of institutionalization
and drug prescription, increase patient’s disability, worsen
patient’s and caregiver’s QoL, contribute to increase costs, but
their influence on cognition is unclear (92).
According to consensus papers based on expert opinion
and systematic revision of RCTs, the general principles for
BPSD management include the following steps: symptoms
evaluation (i.e., type, entity, frequency), recognition and
treatment of possible organic causes or triggering factors, NPT,
pharmacological therapy, educational, and psychological support
for the caregiver (93–96).
Considering the limited evidence and concerns on the safety
of drug treatment (94–99), all guidelines agree that individualized
and person-centered NPT are the first-line treatment for BPDS
and the use of a pharmacological strategy should be considered
only later, using the least harmful drug for the shortest time.
Some theoretical models have been proposed to explain
the role of non-pharmacological approaches to BPSD (100).
The progressively lowered stress threshold (PLST) model
suggests that, with disease progression, people with dementia
experience increasing vulnerability to stress and external stimuli
because of the environmental demand. According to the
PLST model, minimizing environmental demands that exceed
functional capacity, and regulating activity and stimulation
levels throughout the day can reduce agitation. According to
the competence-environmental press (CEP) model, the highest
individual functioning results from optimal combinations of
environmental conditions and personal competencies. The CEP
model suggests that the right balance between individual
ability and external environmental demands results in adaptive
behaviors, while excessive or reduced environmental activities
may result in BPSD. Both models suggest that BPSD can be
reduced or managed by modifying environmental factors that
place too much demand or pressure on the patient.
A different approach is provided by the need-driven,
dementia-compromised behavior (NDB) that conceptualized
BPSD as the result of the combination between the inability
of the caregiver to understand patient’s needs and the inability
of the patient to express them. Therefore, BPSD may represent
patient’s attempts to express physical or emotional distress due
to unmet needs. According to this model, NDB are induced
by both background (i.e., cognitive, neurological, health, and
psychosocial variables) and proximal factors (i.e., environmental
and situational issues such as pain, fatigue, and noise); while
background factors are quite stable, proximal ones are modifiable
and represent the target for the interventions (101, 102).
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The number of reports and reviews on the efficacy of
NPT of BPSD has increased in recent years. Most studies
have been performed in nursing homes on patients with
advanced dementia. The interventions range from sensorial
to psychological and behavioral approaches, and include
environmental redesign, validation therapy, reminiscence
therapy, light therapy, aromatherapy, massage and other
sensory-based strategies, acupuncture, music therapy, pleasant
events and activity engagement, behavioral management
techniques, caregiver training (70, 99, 103–107). Potential
benefits of these interventions have been documented, but the
strength of evidence is overall low and the great heterogeneity
in terms of type of intervention, follow-up duration, type
of outcome measures hamper comparison across studies. In
particular, there are no conclusive results for validation and
reminiscence therapy, the effectiveness of light therapy is not
clear, aromatherapy is better than no treatment. The small body
of evidence for other sensory interventions, such as massage and
touch therapy, suggests they could be viable treatment options,
especially given the ease of implementation andminimal training
involved. No effect has been documented for acupuncture and
transcutaneous electrical nerve stimulation. Music therapy and
behavioral management techniques seem to cause a short-term
reduction of BPSD, but long-term efficacy is unclear.
In general, no conclusions can be drawn on the safety of
these NPT, because this feature is largely unexplored (103). Some
reports indicate the NPT to BPSD to be potentially cost-effective
(70, 99, 106), but further research is needed on this point.
Factors that may predict a better response to these
interventions include a higher level of cognitive functioning,
fewer difficulties in ADL and communication, and relative
preservation of speech, while staff barriers and pain are associated
to worse outcome (108).
Independently from the results, all studies underline the
relevance of a tailored individualized intervention and a careful
and close monitoring of the outcomes to ameliorate and
modulate the treatment (109, 110). Since pain and discomfort
may cause difficulties in communication and self-management,
and contribute to BPSD, these factors should be carefully
searched and treated (111, 112).
In our opinion, the type of setting of interventions is an
important point, as it may influence aims of the treatment
and outcomes. The majority of studies on BPSD have been
performed in nursing homes, where different health professionals
(i.e., physicians, psychologists, nurses) are involved, and they
may interact to offer a better outcome (111). In contrast, as
caregiver is often the only figure that manage patients’ BPSD at
home, future studies should address the role of NPT for BPSD in
non-institutionalized people with dementia (106).
OCCUPATIONAL THERAPY
Disease progression reduces the ability to participate in
occupations—mainly ADL, IADL, leisure and social activities—
in patients with dementia, leading to a negative impact on QoL
and well-being of patients and caregivers (113–117). Therefore,
improving and preserving ADLs is one of the most important
patient-related outcome in dementia (118).
To increase functional abilities and enhance independence,
occupational therapy (OT) uses a combined approach including
activity simplification, environmental modification, adaptive
aids, problem-solving strategies, skill training, and caregiver
education (119, 120), according to the bio-psycho-social model
of health proposed by the ICF (116). An RCT on patients with
mild-to-moderate dementia living in the community showed that
a multimodal OT approach, including cognitive and behavioral
interventions to train patients to compensate for cognitive
impairment and caregivers to cope with patients’ abnormal
behavior, was effective in improving ADL and in reducing
caregiver’s burden with effects lasting for up to 12 weeks (121). A
review including seven RCTs showed that OT interventions may
maintain physical function and ADL in community-dwelling
persons with dementia (105, 122).
OT seems also effective in reducing BPSD, increasing
patient’s participation, improving physical performance, and
QoL and reducing negative communication (123–129). These
positive results have been confirmed in a recent review
that showed OT interventions based on sensory stimulation,
environmental modification and functionally oriented tasks, to
be effective in improving BPSD and depression in dementia
(130). Among environment-based interventions, ambient music,
aromatherapy, and Snoezelen (i.e., a soothing and stimulating
multisensory environment) were modestly effective in reducing
agitation, but they did not have long-term effects, while the
evidence to support bright light therapy for mood and sleep
disorders was only preliminary (131).
An evidence-based review suggested that patient-centered
leisure activities that involve social interaction may enhance
caregiver satisfaction with visits for residential patients, while
interventions focused on ADL and IADL may ameliorate
patients’ well-being and QoL. Social participation interventions,
mainly involving people in the early or middle stage of the disease
when verbal competence is still fairly spared, were shown to have
at least short-term positive effect on patient’s well-being (132).
Gitlin and collaborators proposed a 4-month structured home
occupational therapy intervention, the Tailored Activity Program
(TAP), that provided persons with dementia with activities
tailored to their abilities, while caregivers were trained to
effectively use these activities in daily life and to generalize them
to different settings (133). Besides being effective in reducing
caregiver burden, in that caregiver had significantly more free
time, TAP was demonstrated to be highly cost-effective (123).
Some general considerations have been issued on OT: (a)
programs should be tailored to elicit the patient’s highest level
of retained skill and interest; (b) cues for assisting people
with AD to complete tasks should be short and provide
clear direction; (c) compensatory strategies in the form of
environmental modifications and simple adaptive equipment
should be specifically tailored to the specific needs of single
patients; (d) caregiver training and involvement are essential in
implementing individualized programs (134).
OT is recommended by several guidelines for dementia
management (135–137). The recently published clinical practice
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guidelines and principles of care for people with dementia in
Australia reported important evidence-based recommendations
for occupational therapists, based on the most updated high-
quality evidence (138). However, well designed RCTs are lacking
on this topic and often the studies use different approach, lacking
specificity. Therefore, more research is needed to identify specific
OT components and the optimal dosage of the intervention and
to evaluate the long-term effects and the contraindications of OT
in patients with dementia.
Subtle functional changes in highly cognitively demanding
activities have been reported in individuals in the early
stage of the disease, suggesting that, similarly to cognition,
function declines along a continuum from healthy aging to
dementia (139–141). Incorporating more challenging and high-
level activities into the assessment of patients with early dementia
may increase the sensitivity of functional measures, thus enabling
early detection of impairment and expanding the window for
timely OT interventions (142). These points may represent
directions for future research on this topic.
PSYCHOLOGICAL THERAPY
In recent years, the growing awareness of the deep emotional
impact of the diagnosis of dementia and of the need of a holistic
and individualized approach to the disease, has led to a rising
interest on the psychological care for persons with dementia
(143).
Actually, experiencing depression and anxiety is very common
in people with dementia, even if there is a lack of consensus
on their prevalence rates as diagnostic criteria may vary
among studies (144–147). All studies agree that depression
and anxiety may have significant functional impact. Consistent
evidence suggests that, in people with dementia, the severity
of depression increases the severity of neurological impairment,
institutionalization (148, 149), and caregiver burden (150), while
anxiety is associated with decreased independence and increased
risk of nursing home placement (151).
Although different from each other, depression often co-
occurs with apathy. Apathy, which is defined as a loss or
diminution of goal-directed behavior, cognition or emotion (152)
is one the of the most common neuropsychiatric symptom in
AD, with a prevalence ranging from 19 to 88% (153). Even
if symptoms like social withdrawal or reduced initiation and
motivationmay occur both in apathy and depression, true apathy
is usually not associated with depressive symptoms, such as
sadness, guilt, or hopelessness (154). The presence of apathy
seems to be related to greater caregiver burden, faster functional
impairment, reduced QoL and increased morbidity, being a
reliable longitudinal predictor of death in people with dementia
(155–157).
Many recommendations underscored that the treatment of
anxiety and depressive symptoms should be an essential part
of the management of AD and other dementias (93, 152, 153)
and suggested that psychological interventions could be effective
for these patients (158). However, empirical evidence supporting
the efficacy of psychological interventions is rather sparse (159),
mainly because a broad group of interventions that are termed
as psychological ones have been included in reviews (160,
161), but actually are not based on well-defined theory-driven
psychological interventions.
According to the World Health Organization, cognitive
behavioral therapy, psychodynamic therapy, interpersonal
therapy, and supportive counseling (i.e., Rogersian person-
centered therapy) are the main psychotherapeutic approaches
with evidence of effectiveness in treating depression and
anxiety in adults (162). Studies that have adopted one of these
approaches have been included in a recent systematic review
on psychological interventions for anxiety and depression in
dementia or MCI (six RCTs, psychological treatment: n = 216
patients, usual care or placebo intervention: n = 223) (163).
The Authors concluded that there is evidence that psychological
interventions added to usual care can reduce symptoms of
depression and clinician-rated anxiety in dementia and that
psychological interventions have the potential to improve
patient’s well-being, while no effect was found on ADL, self- and
caregiver-rated patient’s QoL, BPSD, cognition, or caregivers’
self-reported depressive symptoms (163).
A recent systematic review concluded that the strongest
evidence supported the use of short-term group therapy soon
after dementia diagnosis to reduce levels of depression and
enhance QoL, while tailored and multi-component interventions
seemed to reduce inappropriate behaviors in patients living
in nursing homes with mild-to-moderate levels of impairment
(164).
Systematic reviews indicated a variety of NPTs (e.g., one-to-
one activities, activity programs tailored on patients’ preferences,
individualized cognitive rehabilitation, music therapy, art
therapy) as potentially effective and safe in reducing apathy,
although none of them is strictly a psychological intervention
(165, 166).
Overall, the proposed psychological approaches were
methodologically heterogeneous, some of them lacked specificity
and conceptual clarity and often the description of the
interventions was quite generic. Moreover, most studies included
patients in the first stage of dementia, because cognitive decline
prevents the understanding and feasibility of psychological
therapy in advanced stages.
In conclusion, the current evidence for psychological support
and psychotherapy in AD and dementia is limited and not
conclusive. Therefore, further studies are needed to demonstrate
which psychological interventions may lead to better outcome
and to identify common factors across different approaches
that may be effective in enhancing well-being of persons with
dementia.
MULTICOMPONENT AND
MULTIDIMENSIONAL STRATEGIES
The proposal of multidimensional protocols of treatment is based
on the hypothesis that combining different approaches may be
the most suitable intervention to improve different outcomes
in AD. An Italian group developed the Multidimensional
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Stimulation Therapy (MST), a multidimensional approach that
combined cognitive stimulation, recreational activities, OT and
physical exercises, and demonstrated that MST was more
effective than a cognitive-specific intervention in improving both
behavioral and functional outcomes in AD patients (167, 168). A
recent fMRI study suggested restoration of neural functioning as
the mechanism underlying the positive effects of MST (169).
Similarly, the Meeting Centers Support Program (MCSP),
a supportive person-centered approach for mild-to-moderate
dementia patients living in the community and their caregivers
was implemented in the Netherlands. MCSP is based on
the combination of recreational activities and psychomotor
therapy for patients, psico-educational and support groups
for caregivers, social activities for both, and regular center
meetings (170). MCSP yielded promising results in terms
of user satisfaction, reduction of patients’ behavioral and
emotional disturbances, decrease of caregivers’ burden and
delayed institutionalization (170–173). A study exploring the
dissemination and implementation of MCSP to different
European countries is currently ongoing (174).
Actually, some systematic reviews demonstrated that
multicomponent interventions were more effective than single
activities in improving general well-being of both persons with
dementia and their caregivers (70, 175), and in hospitalized older
adults with cognitive impairment (176, 177).
As dementia represents a complex disease with cognitive,
psychological, functional and behavioral symptoms, the adoption
of multicomponent approaches may represent a winning
strategy, in agreement with the biopsychosocial model of care,
upon which any rehabilitative intervention is founded. The
encouraging results obtained so far suggest further studies in this
area of research.
COMPLEMENTARY AND ALTERNATIVE
MEDICINE
Complementary and alternative medicine (CAM) has become
more commonly used over the last decade and has been applied
to a wide range of health problems, including dementia. We
will report evidence on the main CAM types, i.e., aromatherapy,
music therapy, art therapy, massage, and touch. These NPTs are
part of the main category of sensorial stimulation techniques,
i.e., interventions aimed to promote the arousal of the patients’
senses (178).
AROMATHERAPY
Among CAM, aromatherapy is probably the most familiar to
consumers. Aromatherapy is part of phytotherapy and is based
on the use of pure essential oils from fragrant plants to relieve
health problems and improve QoL. The potential effects of
essential oils are varied, including promotion of relaxation and
sleep, relief of pain (179), reduction of depressive symptoms.
Aromatherapy might be a useful intervention for people
with cognitive disturbances, who are confused, or for whom
verbal interaction is difficult and current conventional medicine
provides only partial benefit (180). Indeed, aromatherapy has
been used to address BPSD (181–186) and sleep disturbances
(187–189) and to stimulate motivational behavior (190). A
meta-analysis identified only seven RCTs and concluded that
the benefits of aromatherapy for people with dementia are
equivocal, mainly because of severe methodological problems
(191). Therefore, the effects of aromatherapy in this condition
should be better explored in high-quality RCTs.
MUSIC THERAPY
Music therapy (MT) can be defined as an NPT that uses
music or sound as a non-verbal communication tool to induce
educational, rehabilitative or therapeutic effects in several
disease, including dementia. Music-based interventions can
be conducted in single patients or in group, and they most
consist of singing, listening, improvising or playing along
on musical instruments (192). We can therefore classify MT
in active and passive interventions. Since most studies on
MT included both active and passive techniques, which type
of intervention can be more effective in dementia is still
unclear (193).
There is substantive literature reporting the importance
and benefits of music and music therapy programs for older
adults, and more specifically for those with dementia (194–
199). Neurophysiologic and psychological data provide the
theoretical basis for the use of music therapy. Studies showed
that sound can exert a significant action on the brain (200–204)
by activating a large number of cortical and subcortical areas,
and, particularly, the limbic and paralimbic areas devoted to
emotional processing (205). From a psychological point of view,
music facilitates communicative and relational processes and
emotional expression (206). Moreover, since music can stimulate
both motor and cognitive functions, it can be an efficient tool
for rehabilitation (207). A growing amount of evidence shows
that patients with dementia can enjoy music, and their ability
to respond to music is potentially preserved, even in the late
to severe stages of disease when verbal communication may
have ceased. Several studies reported the efficacy of music to
treat BPSD (208–213), to enhance communications, relational
processes and participation (199, 214–216), and to maintain or
increase cognitive functions (217–222). However, reviews on this
topic pointed out the methodological limitations and the scarce
quality of previous studies and questioned the specificity of the
effect of music that was found to be nomore beneficial than other
pleasant activities (223, 224).
A recent meta-analysis concluded that a music-based
therapeutic intervention probably reduces depressive symptoms
but has little or no effect on agitation or aggression, emotional
well-being or QoL, overall behavioral problems and cognition
in dementia, while effects on anxiety or social behavior, and
long-term effects are unclear (192).
A recent RCT found that music therapy added to
pharmacotherapy yielded no further benefits for language and
verbal communication in comparison to pharmacotherapy
alone, but this integrated approach could improve the
psycho-behavioral profile (225).
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In conclusion, the question whether music may have specific
effects in patients with dementia is still open. Future studies
should employ larger sample sizes, include all important
outcomes, in particular positive ones, such as emotional and
social well-being, and examine the duration of the effect in
relation to the overall duration of the treatment and the number
of sessions (192, 226).
ART THERAPY
The British Association of Art Therapists defines art therapy as
“a form of psychotherapy that uses art media as its primary mode
of communication” and underscored that (a) clients who are
referred to an art therapist need not have experience or skill in
art; (b) the art therapist is not primarily concerned with making
an aesthetic or diagnostic assessment of the client’s image; (c) the
overall aim of its practitioners is to enable a client to change and
grow on a personal level through the use of art materials in a safe
and facilitating environment” (227).
Whether art therapy can be useful and may represent
an effective rehabilitative strategy for people suffering from
dementia is a debated issue (110, 228). It has been suggested
that patients with dementia can produce and appreciate visual art
and that aesthetic preference can remain stable, despite cognitive
decline (229).
Case reports, observational studies, small trials and anecdotal
evidence suggest that art therapy can engage attention, provide
pleasure, and improve BPSD, social behavior, and self-esteem,
contributing to the individual sense of well-being in dementia,
and that these effects may be long-lasting (230–243). However,
few high-quality studies have been performed so far on this
topic, and there is too little empirical evidence to prove the
effectiveness of this type of CAM. Therefore, RCTs with adequate
methods and appropriate outcomes are needed to support the
efficacy and define optimal conditions for the use of art therapy in
dementia.
MASSAGE AND TOUCH
Massage and touch have been suggested as a CAM or supplement
to other treatments to reduce a range of conditions associated
with dementia. Evidence suggests that massage and touch may
relax older people with dementia, reduce some BPSD, such as
pacing, wandering and resisting care, improve appetite, sleep
and communication problems, and, to some extent, counteract
cognitive decline (244–250).
Massage seems to produce different physiological effects
such as a decrease in pulse and respiration and an increase
in body temperature (251). Physiological models suggest that
the effects of massage may be mediated by the production of
oxytocin that can reduce discomfort, agitation, blood pressure
and heart rate, and improve mood. On the other hand,
psychological models suggest that massage can help people
with dementia to retain a sense of meaningful and reassuring
communication even when words fail and may help to activate
memories (252).
A recent meta-analysis of 11 RCTs showed that massage and
touch interventions may have significant effect on physical non-
aggressive, verbal aggressive and non-aggressive behavior, but the
relatively small sample size and the low quality of the included
studies do not allow to draw a firm conclusion on the effect on
BPSD or any useful suggestion for clinical practice (253).
As for other CAM types, RCTs of better methodological
quality are needed to provide evidence supporting the benefit of
massage and touch in dementia.
NEW TECHNOLOGIES
The availability of new technologies, their diffusion and, for some
of them, the relatively cheap price, resulted in a progressively
larger number of studies exploring their role in dementia.
We will briefly summarize evidence on the application of
information and communication technologies (ICT), assistive
devices, domotics, virtual reality, gaming and telemedicine to
monitor, and treat people with dementia.
ICT, ASSISTIVE DEVICES AND DOMOTICS
Recent technological advances in ICT, including computational
devices, robotics, machine learning algorithms, miniaturization
of sensors and technologies, as well as the reduced costs of
these devices increased the availability of intelligent devices and
technology-embedded environments to support the daily life
of persons with dementia and their caregivers, and to assess
disease severity and progression (254–256). Nowadays, devices
and sensors can be integrated into the patient’s environment as
part of a “smart” or automated home, or in the patient’s clothes to
offer healthcare professionals a much clearer view of the patient’s
condition and activity than that available from short periods of
monitoring in a clinical setting (257). In particular, ICT allows
continuous monitoring of patient’s performance and actions in
real time and real-life situations (258–260).
Moving freely outdoors is considered an important ADL
outcome associated with the ability to maintain independence
and participation. The development of technologies, which allow
people with dementia to stay outdoors in a safe and secure
way, is considered a priority research area. Therefore, tracking
technologies that record the position of the patient based on
global positioning system (GPS), and can localize him/her if
lost is the most developed area of ICT research in dementia
(261–265). Tracking technology devices can promote perceived
safety and security among caregivers and relatives of people with
dementia (266), in that they can locate the patient at any moment
and represent a precious support in everyday life (263, 267).
Many studies in this area focused on the perspective of relatives
and/or healthcare staff, but only a limited number of them
explored the experience of people when wearing a GPS tracking
technology (259, 262, 268, 269).
Another application of ICT is represented by devices that can
be used for surveillance and management of high-risk behaviors
and may replace more severe forms of physical restraints (270–
272). Acoustic sensors placed in the living room or bedroom can
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record noise, or patient’s movement. Cameras or GPS devices
can also be used to allow caregivers or staff to take actions
when the patient is in a potentially dangerous condition, without
restricting freedom of movement. Furthermore, patients can
wear a chip in their clothes to give them access to certain parts of
the building, while preventing them to move to other forbidden
or dangerous areas (266).
However, the application of surveillance technologies to
the care of people with dementia led to considerable ethical
debate. Indeed, opponents of this approach claim that the
continuous monitoring may represent a breach of patient’s
privacy and freedom and argue that tracking devices may
diminish human contact between patients and the environment
(273). A systematic review on the ethical and practical concerns
of surveillance technologies in residential care for people with
dementia concluded that there is no consensus and underlined
the need for clearer policies on this topic (274). A recent
descriptive review showed that a significant portion of current
intelligent assistive technology is designed in the absence of
explicit ethical considerations, and thismay represent a structural
limitation in the translation from designing labs to bedside
(275). The Authors called for a coordinated effort to proactively
incorporate ethical considerations early in the design and
development of new ICT products (275).
ICT has also been applied to monitoring and prevention
of falls in dementia. Body-worn gyroscopes measuring angular
velocity, sensors to measure the acceleration of the trunk, and
inertial sensors may detect when a fall occurs, along with
the causes of the fall (276–279). Among non-wearable systems
cameras, motion sensors, microphones and floor sensors have
been applied to this aim (280, 281). Information obtained by
accelerometers contained in a wristband may result in vibratory
and visual feedback to increase the patient’s awareness of their
risk of falling (282). Similarly, a shoe insole that delivers
vibration may prevent falls and improve gait and balance.
Research projects are currently exploring how exoskeletons
can correct and assist postural balance and improve overall
function. Technology will hopefully provide many more options
for assessment, prevention, and intervention in this area of health
care (283).
Video and audio analysis techniques, computerized testing
and actigraphy, besides being useful to promote patients’ safety,
may represent promising tools to improve functional and
cognitive assessment of patients with AD (256). For instance,
automatic speech analysis techniques through computerized
speech recognition interfaces could represent a non-invasive and
cheap method to collect information on verbal communication
impairment in patients with cognitive disorders (284). Video
processing technologies can be adopted to obtain pragmatic,
ecological, and objective measures to improve assessment of
ADL, and to provide additional information that cannot be
gathered in a clinical setting (285).
ICT can be used for the assessment of agitation, one of
the most challenging symptoms to manage for caregivers (286,
287). A core feature of agitation is excessive motor activity,
and accelerometers can objectively measure abnormal motor
activity, speech analyses may assess verbal aggression, and
automated video analysis and activity recognition techniques can
detect activities andmovement sequences that underline physical
aggression (288). Sensors measuring electrodermal activity could
early detect agitation in persons with dementia. These devices
could theoretically support nursing staff in recognizing early
warning signs of BPSD, but further studies in a clinical setting
are needed to confirm this hypothesis (289).
Overall, this is a challenging domain for clinicians, who should
define the clinically relevant markers, and for ICT engineers,
who should adapt the technical constraints to the clinical
requirements.
Assistive technologies can support and facilitate disabled
people in ADL (290). For instance, external cueing systems
can assist people with cognitive disabilities by reminding them
to perform a task at the appropriate time (e.g., take their
pills), or by providing guidance through a task (291–293),
and sensors recording a patient’s position in space may help
in navigation through environment (294). Moreover, assistive
technologies may help to support decision-making in vocational
and personal health domains (295), to read (296), or use the
telephone (297).
Domotics is another important field of research, because
nearly three quarters of older adults with dementia are cared
for in their own homes (298), and there is a strong correlation
between home environment and disability-related outcomes
(299). Dementia-specific adapted home environment and related
assistive devices may be helpful for both the patient and the
caregiver (300–302). Changes to home environmentmay result in
lack of familiarity for the patient, and earlier home modifications
might enable individuals with dementia to adjust to their adapted
environment (303).
Future smart homes will incorporate intelligent interfaces
embedded in everyday objects, such as furniture, clothes,
vehicles, and smart materials to observe the residents and provide
proactive services (304). One of the key-supporting features of
a smart home is the ability to monitor the ADL and safety
of people, and to detect changes in their daily routines. With
the availability of inexpensive low-power sensors, radios, and
embedded processors, smart homes may be equipped with large
amounts of networked sensors, which collaboratively process
and make deductions from the acquired data on the state of
the home, and the activity and behavior of its residents (305–
310). Therefore, the smart home technology seems to be a
promising and cost-effective way of improving home care for
people with dementia in a non-obtrusive way, allowing greater
independence, maintaining good health, preventing social
isolation, and relieving the workload from family caregivers and
health providers (311).
The data on domotics are encouraging but some factors, e.g.,
the accessibility and affordability of these devices and the limited
caregiver’s awareness of their availability and utility, may prevent
a more widespread use of these technologies (312).
In conclusion, ICT applications are rapidly expanding to
support assistive and clinical tasks in people with dementia, but
structural limitations to successful adoption include partial lack
of clinical validation and insufficient focus on patient’s needs.
Clinicians and stakeholders involved in the implementation and
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management of dementia care across ICT applications should
collaborate to facilitate the translation of medical engineering
research into clinical practice (313).
VIRTUAL REALITY AND GAMING
Virtual reality (VR) allows a user to navigate through, and
interact with, a virtual environment that is a 3D digital space
generated by computing technology and consisting of objects
or entities seemingly “real” because they share at least one
attribute of the real thing, without sharing all of its physical
characteristics (e.g., volume, weight, surface friction) (314).
The potential applications of VR systems to assess and train
AD patients has been reported by several studies (315–320).
Cognitively impaired patients can be exposed to computer-
generated virtual environments, where they can safely perform
quasi-naturalistic real-life activities and tasks to assess and/or
treat cognitive and motor deficits under a range of conditions
that are not easily controllable and quantifiable in the real
world (321). The most specific domains for VR diagnostic
and training purposes in AD patients include attention (322),
executive functions (323–326), memory (327–333), orientation
(322, 327, 334–336), and ADL (337, 338). Research is currently
focusing on the design of VR based tests aimed to be more
ecological and sensitive compared to common pen-and-paper
tests. A recent study proposed a novel AD screening tests
based on virtual environment and game principles to evaluate
memory loss for common objects and recent events, and language
changes (339).
The advantages of VR in comparison to traditional assessment
and training tools are represented by the naturalistic situations,
the safety from potential dangers that could occur in real-
life situations and the enhancement of motivation because
of its gaming, interactive, and immersive quality. For these
reasons, computer-driven simulations of real-life environments
can bridge the gap between traditional test outcomes
and compensatory strategies that are transferable to daily
life.
Since most of the evidence on the role of VR come from single
case reports or to restricted samples, the debate on its role in
patients with dementia is still open.
In this scenario, serious games (SG), i.e., interactive
virtual simulations to represent real situations, otherwise
hardly reproducible, allow the player to act in a real-life-like
environment, or a fictitious scenario that serves as a gym for
deliberately decontextualized learning. SG are widely recognized
as promising non-pharmacological tools to assess patient’s
cognition and function (340, 341), and to treat, stimulate, and
improve patient’s well-being (342). Boosted by the publication of
a Nature letter showing that video game training can enhance
cognitive control in older adults (343), SG specifically adapted
to people with AD have been developed and employed to
train physical and cognitive abilities, showing preliminary but
encouraging results (341, 344–348).
A recent literature review concluded that game-based
interventions can positively affect both physical health by
improving balance, gait and voluntary motor control and
cognitive function by enhancing attention, memory, and visuo-
spatial abilities in older adults and in patients with dementia
(349). Both physical and cognitive games seem to have a positive
impact on social and emotional function, improving mood and
increasing positive affect and sociability (350).
Since the use of SG in neurodegenerative disorders is
expanding, recent studies have provided recommendations in
terms of ergonomic choices for their design, and to create
customize SG specific to the target users (351). Considering that
the actual recommendations are gathered from a relatively small
group of experts working in the domain of SG for health, further
work is needed to verify if they hold true for a wider expert
population, and their applicability to patients.
On the basis of these preliminary data, clear evidence on
the effectiveness of VR and SG for the assessment and training
of people with AD requires further research that should adopt
methodologies based upon best practices from clinical trials and
incorporate behavioral and neurophysiological data.
TELEMEDICINE
Technology provides new opportunities for interventions to
improve quality and access to health care. Since dementia is a
chronic disease, with issues related to continuous long-term care
and limited accessibility to medical service, telemedicine could
be a valuable mean to provide assessment and care to dementia
patients at home (352). Indeed, telemedicine can provide
follow-up care to help people with dementia to maintain their
independence and continue living in their own homes, improve
their safety, (353, 354), ameliorate clinical outcomes, and reduce
access to health services (355, 356). Moreover, likely because of
the reduction of the discomfort due to travel, telemedicine was
found to be an independent predictor for increased treatment
duration (357). Telemedicine appears to be very promising
and effective in the context of dementia assessment, especially
in countries, such as the USA, where there are several rural
retirement communities that are still medically underserved. A
recent study conducted in a Southern California community
showed not only that telemedicine was able to improve access
and quality of dementia care, but also that most of the patients
preferred the telemedicine consult compared to the traditional
one (358).
Several studies confirmed the feasibility to perform cognitive
assessment via telemedicine in elderly subjects with dementia
and showed a good agreement with conventional face-to-face
testing, and a high level of user satisfaction (359–362). However,
since data are still preliminary, there is no consensus on the
best practices for conducting neuropsychological assessment by
telemedicine (362).
Besides the diagnostic evaluation and follow-up monitoring,
telemedicine interventions for dementia include internet-based
information and support groups, robotic companions, the use of
smartphones to report symptoms (258, 363, 364), and cognitive
rehabilitation training (365).
Telemedicine has been applied to support caregivers of
people with dementia through in-home video monitoring and
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TABLE 1 | Summary of the level of evidence, main positive outcomes, and limitations of the non-pharmacological treatment for Alzheimer’s disease and dementia.
Treatment Subtype Evidence Main positive outcomes Limitations
Exercise and motor
rehabilitation
Moderate • Reduction of BPSD
• Improvement of ADL
• Limited evidence for cognition, QoL, depression,
mortality, caregiver burden
• Few comparative studies exploring the most
effective exercise intervention
• Unclear duration and intensity of activity
Cognitive intervention CS Moderate • Improvement of general cognitive function
• Small effect on mood and QoL of patients and
caregivers
• Unclear long-term effect on cognition
• Heterogeneity of the outcomes
CT Small • Enhancement of performance in trained and
similar tasks
• No generalization effect to daily function
• Low quality studies
CS+CT Small • Improvement of general cognitive function • Heterogeneity of treatment
• Heterogeneity of dementia severity
• Few high quality RCTs
CST Moderate • Improvements of general cognitive function and
specific cognitive domains
• Small effect on QoL
• Improvement of caregiving relationship
• Small effect on depressive symptoms and QoL of
caregivers
• Not all services offer this treatment
• Unclear effect on BPSD and ADL
Occupational therapy Small • Improvement of ADL, social participation, QoL
• Reduction of BPSD and depression
• Reduction of caregiver burden
• Unclear optimal duration
• Unclear long-term effect
• Mixed approaches
• Few high quality RCTs
Psychological therapy Small • Reduction of depression, anxiety, and apathy
• Enhancement of patient’s well-being
• No comparative studies between different
psychological treatments
• No long-term studies
• Few high quality RCTs
Multicomponent/
multidimensional
strategies
Small • Reduction of BPSD
• Improvement of some cognitive domains
• Delayed institutionalization
• Reduction of caregiver burden
• Persistence of effect
• Generalization to everyday life
• Limited implementation and dissemination
• Few high quality RCTs
Aromatherapy Very small • Reduction of BPSD and sleep disturbances
• Improvements in motivational behavior
• Severe methodological issues
• Few high quality RCTs
Music therapy Small • Reduction of depression
• Improvement in communication, social
participation, relations and cognition
• Unclear long-term effect
• Small sample size
• Low-quality studies
Art therapy Very small • Reduction of BPSD
• Improvement of attention
• Improvement of social behavior and self-esteem
• Unclear long-term effect
• No RCTs
Massage and touch Very small • Reduction of BPSD
• Improvement of mood, sleep, appetite
• Small sample size
• Low-quality studies
ADL, activities of daily living; BPSD, behavioral and psychological symptoms of dementia; CS, cognitive stimulation; CST, Cognitive Stimulation Therapy; QoL, quality of life; RCT,
randomized controlled trial; CT, cognitive stimulation.
recording and feedback to help managing difficult situations
(366). Telephone-based support groups is a promising way
to provide support for caregivers, but research is only at the
beginning (367). A systematic review on technology-driven
telemedicine interventions, such as online training and support
programs, for caregivers of persons with dementia concluded
that included studies yielded positive findings in terms of mental
health outcomes, but their marked heterogeneity impeded robust
conclusions (368).
Overall, establishing systems for the care of dementia patients
and their caregivers using telemedicine technologies seems to
be feasible, but the evidence on clinical benefits is still scarce,
cost-effectiveness data are lacking, and there is very little evidence
of widespread practical applications (369).
LIMITATIONS OF THE STUDY
The main limitation of the present review is its narrative design,
but a systematic one would have not been feasible because of
the larger number of studies on NPT in AD and dementia.
Another limitation is the use of two search engines, only (i.e.,
PubMed and the Cochrane database of systematic reviews).
Searching in other databases (e.g., Embase, PsycINFO, Web of
Science) would have yielded more pieces of literature, but it has
been suggested that MEDLINE, which is completely covered by
PubMed, may produce a sufficiently extensive coverage (370).
A study comparing 15 databases for RCTs on CAM showed
low overlap between databases and indicated that comprehensive
CAM literature searches will require multiple databases (371) but
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this appear a minor problem in the present review because of the
overall low quality of studies on CAM interventions.
CONCLUSIONS
Appropriate management of patients with AD and dementia is a
significant public health concern, given the limited effectiveness
of pharmacological therapies combined with their potentially
life-threatening side effects. The development of effective NPT
for these conditions is of paramount importance, and a large
number of interventions has been proposed.
The interventions reviewed in this paper show different
level of evidence of efficacy on different outcomes that are
summarized in Table 1. Some of them share methodological
problems that are common to all non-pharmacological studies,
which are typically practice-oriented. They include small number
of high-quality studies or double-blind RCTs, small sample sizes,
heterogeneity in terms of study design, type of intervention
and outcomes, uncertainty about the clinical significance of
outcomes. The landscape of clinical trials has changed since
the introduction of randomization 80 years ago, and new
challenges in their design, conduction, and interpretation
have emerged. Evidence-grading systems are biased toward
RCTs, and they may lead to understatement of findings
from non-RCT studies (372).The direct transposition of the
traditional methods of drug RCTs to the rehabilitation and
NPT scenarios raises some issues, and innovative trial designs
would be helpful in these settings. Moreover, cost-effectiveness
studies are needed to better address the role of NPT for
dementia.
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